Egetis Therapeutics AB (publ) (STO: EGTX)

Egetis Therapeutics AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 17, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2,127	1,633	1,524	1,108	1,233	1,071
Market Cap Growth	34.93%	7.15%	37.56%	-10.17%	15.17%	44.26%
Enterprise Value	2,109	1,550	1,335	939	1,074	784
Last Close Price	5.92	5.58	7.10	6.16	6.85	18.08
Forward PE	-	-	-	-	4.90	-
PS Ratio	25.41	28.34	67.42	29.00	30.32	12.97
PB Ratio	5.44	2.99	3.01	2.10	1.95	4.37
P/TBV Ratio	4.81	3.02	3.04	2.13	1.98	4.37
EV/Sales Ratio	31.06	26.91	59.07	24.58	26.41	9.50
Debt / Equity Ratio	0.35	0.21	0.01	0.01	0.01	0.00
Asset Turnover	0.12	0.09	0.04	0.06	0.08	0.32
Inventory Turnover	415.00	314.62	219.38	50.34	-	-
Quick Ratio	0.95	3.27	2.80	3.85	4.21	10.72
Current Ratio	0.98	3.33	2.98	3.90	4.28	10.76
Return on Equity (ROE)	-81.30%	-62.16%	-37.51%	-18.05%	-40.66%	-26.46%
Return on Assets (ROA)	-34.12%	-30.30%	-21.78%	-10.22%	-22.42%	-16.26%
Return on Capital (ROIC)	-42.12%	-34.29%	-23.68%	-11.27%	-25.14%	-17.93%
Earnings Yield	-18.92%	-20.02%	-12.72%	-9.43%	-14.44%	-5.74%
FCF Yield	-14.25%	-17.05%	-11.39%	-11.76%	-10.92%	-5.85%
Buyback Yield / Dilution	-29.11%	-33.86%	-7.97%	-166.96%	-30.54%	-6.08%
Total Shareholder Return	-29.11%	-33.86%	-7.97%	-166.96%	-30.54%	-6.08%

Source: S&P Capital IQ. Standard template. Financial Sources.